-Advertisement-
-Advertisement-
Cornea and External Disease
Study finds TTHX1114 enhances visual recovery, corneal deturgescence after DSO
TTHX1114, an engineered FGF1, when administered in a dose-responsive manner, can enhance the rate of visual recovery and corneal deturgescence following Descemet stripping only (DSO), according to data presented at ASCRS 2023. Smaller descemetorhexis was associated with a faster recovery, while the presence of comorbid diabetes appeared to delay recovery....
Read More-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
-Advertisement-
Stay Connected! Join Our Newsletter
Contact
Grandin Library Building
Six Leigh Street
Clinton, New Jersey 08809
+908-505-8899
[email protected]
© 2023 Ophthalmology 360® is a trademark of International Healthcare Media, LLC. All rights Reserved